Bio-Thera Solutions, Ltd. (SHA:688177)
China · Delayed Price · Currency is CNY 17.11
+0.03 (0.18%)
At close: Jul 31, 2026
Bio-Thera Solutions Market Cap
Bio-Thera Solutions has a market cap or net worth of 7.08 billion as of July 31, 2026. Its market cap has decreased by -44.93% in one year.
Market Cap
7.08B
Enterprise Value
7.62B
Revenue
980.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.11
ChartMarket Cap Chart
Since February 21, 2020, Bio-Thera Solutions's market cap has decreased from 24.93B to 7.08B, a decrease of -71.58%. That is a compound annual growth rate of -17.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 7.08B | -26.06% |
| Dec 31, 2025 | 9.58B | 19.40% |
| Dec 31, 2024 | 8.02B | -53.01% |
| Dec 29, 2023 | 17.08B | 89.35% |
| Dec 30, 2022 | 9.02B | -15.68% |
| Dec 31, 2021 | 10.70B | -18.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biological,Inc. | 8.21B |
| Chongqing Genrix Biopharmaceutical | 8.15B |
| Acrobiosystems | 8.09B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 7.88B |
| Aurisco Pharmaceutical | 7.87B |
| Chengdu Easton Biopharmaceuticals | 7.79B |
| Innovita Biological Technology | 7.71B |
| Daan Gene | 7.65B |